ClinicalTrials.Veeva

Menu

Gallbladder Stenting in FC-SEMS

I

Integrated University Hospital Trust of Verona

Status

Not yet enrolling

Conditions

Biliary Obstruction
Acute Cholecystitis

Treatments

Device: Fully covered self-expandable metal stent
Device: Double plastic pigtail stent plus fully covered self-expandable metal stent

Study type

Interventional

Funder types

Other

Identifiers

NCT06820541
GB-COVER

Details and patient eligibility

About

The goal of this randomized controlled trial is to determine whether primary prophylaxis with transpapillary gallbladder drainage prevents acute cholecystitis after fully-covered self-expandable metal stents placement during endoscopic retrograde cholangiopancreatography for malignant distal biliary obstruction in patients at higher risk of post-endoscopic retrograde cholangiopancreatography acute cholecystitis.

The main question it aims to answer is:

Does prophylactic transpapillary gallbladder drainage reduce the rate of post-endoscopic retrograde cholangiopancreatography acute cholecystitis in high-risk patients? Researchers will compare patients who undergo transpapillary gallbladder drainage to patients without transpapillary gallbladder drainage to see if transpapillary gallbladder drainage reduces the rate of acute cholecystitis.

Participants will:

  1. receive or not transpapillary gallbladder drainage before fully-covered self-expandable metal stents placement
  2. will be followed up at one, three, and six months to ascertain the onset of acute cholecystitis

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients

  • Signed informed consent

  • Patients requiring covered metal stent placement for managing MBO

  • High-risk of post-endoscopic cholangiopancreatography acute cholecystitis according to the following criteria:

  • tumor involvement of the cystic duct orifice confirmed on magnetic resonance imaging, computed tomography, endoscopic ultrasound, or at endoscopic cholangiopancreatography;

  • presence of at least 2 of the following:

    1. gallbladder stones;
    2. CBD diameter ≤ 10 mm;
    3. intraprocedural gallbladder opacification;
    4. cystic duct orifice at risk of being covered by the fully-covered stent

Exclusion criteria

  • History of cholecystectomy
  • Endoscopic retrograde cholangiopancreatography not feasible for duodenal stenosis or failed biliary cannulation
  • Patients with previous gallbladder drainage
  • Acute cholecystitis is already present based on the Tokyo guidelines

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

Transpapillary stenting
Experimental group
Description:
Patients will undergo prophylactic transpapillary gallbladder drainage followed by fully-covered self-expandable metal stent placement for biliary drainage
Treatment:
Device: Double plastic pigtail stent plus fully covered self-expandable metal stent
Standard biliary drainage
Active Comparator group
Description:
Patients will undergo fully-covered self-expandable metal stent placement for biliary drainage
Treatment:
Device: Fully covered self-expandable metal stent

Trial contacts and locations

1

Loading...

Central trial contact

Stefano Francesco Crinò, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems